Arkema SA (0IB0)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 55.33 |
|---|---|
| 52-week range | 45.26 – 64.25 |
| Return, 1 month / 3 months | −3.0% / +0.2% |
| Return, 1 year / 3 years | +11.8% / −23.1% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 33.8% |
| Worst drawdown (1 year) | -22.6% |
| Average daily value traded | 1.43M EUR |
| Dividend yield | 6.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Arkema is a specialty chemicals and advanced materials company based in France. It makes performance materials such as adhesives, coatings, sealants and technical polymers, along with industrial chemicals used in manufacturing. Its customers come from industries including construction, automotive, electronics and packaging, and it supplies these markets across Europe and other regions. The company focuses on materials that add specific properties to finished products, such as durability, lightness or resistance to harsh conditions.
Arkema SA trades under the code 0IB0 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Arkema SA (0IB0) trades on the London Exchange in UK. It last closed at EUR 55.33 on 21 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 1,656 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.8% and over the last three months it rose 0.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.6% | ||
| From 52-week high | -11.9% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.2% | ||
| 6-month return | -4.4% | ||
| 12-month return, skipping the last month | 15.3% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.6% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.43M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −3.0% |
| 3 months | +0.2% |
| 6 months | −4.4% |
| 1 year | +11.8% |
| 3 years | −23.1% |
| 5 years | −40.7% |
Signals
| 50-day / 200-day average | 57.45 / 56.23 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | EUR 3.6000 |
| 23 May 2025 | EUR 3.6000 |
| 17 May 2024 | EUR 3.5000 |
| 15 May 2023 | EUR 3.4000 |
| 23 May 2022 | EUR 3.0000 |
| 26 May 2021 | EUR 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.